During the past decade, Armstrong Center for Medicine and Health conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 16 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 13 clinical trials were completed. i.e. 1300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Armstrong Center for Medicine and Health" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "SerenaGroup, Inc." with 4 trials sponsored and "Johns Hopkins University" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Armstrong Center for Medicine and Health" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SerenaGroup, Inc." with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Armstrong Center for Medicine and Health" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Stage IIIA Breast Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Armstrong Center for Medicine and Health" in a lesser frequency.

Most popular intervention types in "Armstrong Center for Medicine and Health" are "Other" (26 trials), "Drug" (25 trials), "Biological" (11 trials), "Procedure" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Quality-of-Life Assessment" (7 trials), "Docetaxel" (6 trials), "Paclitaxel" (6 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Armstrong Center for Medicine and Health" are 36 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Armstrong Center for Medicine and Health". undefined are not yet recruiting, 4 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Armstrong Center for Medicine and Health, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Armstrong Center for Medicine and Health, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Armstrong Center for Medicine and Health has several departments that took part in Clinical trials: "Richard G. Laube Cancer Center at ACMH" - 3 trials